Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease.
about
Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTsPosterior parahippocampal gyrus pathology in Alzheimer's diseasePotential drug-drug interactions in Alzheimer patients with behavioral symptomsFK506-binding protein 1b/12.6: a key to aging-related hippocampal Ca2+ dysregulation?Neocortical calretinin neurons in primates: increase in proportion and microcircuitry structureEntorhinal cortical defects in Tg2576 mice are present as early as 2-4 months of age.Delayed arousalSelective vulnerability of dentate granule cells prior to amyloid deposition in PDAPP mice: digital morphometric analysesDendritic vulnerability in neurodegenerative disease: insights from analyses of cortical pyramidal neurons in transgenic mouse modelsPericellular innervation of neurons expressing abnormally hyperphosphorylated tau in the hippocampal formation of Alzheimer's disease patients.Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs.Concentration dynamics of nitric oxide in rat hippocampal subregions evoked by stimulation of the NMDA glutamate receptorCortical gyrification and sulcal spans in early stage Alzheimer's disease.Selective vulnerability related to aging in large-scale resting brain networksAge-related increase of sI(AHP) in prefrontal pyramidal cells of monkeys: relationship to cognition.CREB-binding protein levels in the rat hippocampus fail to predict chronological or cognitive agingAge-related reduction in microcolumnar structure in area 46 of the rhesus monkey correlates with behavioral declineMitochondrial base excision repair in mouse synaptosomes during normal aging and in a model of Alzheimer's diseaseThe response of cerebral cortex to haemorrhagic damage: experimental evidence from a penetrating injury model.Accumulation of nuclear DNA damage or neuron loss: molecular basis for a new approach to understanding selective neuronal vulnerability in neurodegenerative diseases.Functional genomics of brain aging and Alzheimer's disease: focus on selective neuronal vulnerability.Evidence for Alzheimer's disease-linked synapse loss and compensation in mouse and human hippocampal CA1 pyramidal neurons.Correlation of cognitive performance and morphological changes in neocortical pyramidal neurons in agingAge-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L transgenic mice.Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's diseaseReduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 miceAge-related changes of neuron numbers in the frontal cortex of a transgenic mouse model of Alzheimer's disease.Repetition priming and cortical arousal in healthy aging and Alzheimer's disease.Calorie Restriction Suppresses Age-Dependent Hippocampal Transcriptional Signatures.The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease.Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1Changes in the structural complexity of the aged brainContributions of impaired hippocampal plasticity and neurodegeneration to age-related deficits in hormonal pulsatilitySelective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4 T.Diffusion Kurtosis Imaging: A Possible MRI Biomarker for AD Diagnosis?Comparison of catalase immunoreactivity in the hippocampus between young, adult and aged mice and ratsChronic type 2 diabetes reduces the integrity of the blood-brain barrier by reducing tight junction proteins in the hippocampus.The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals.Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model.Estrogens and age-related memory decline in rodents: what have we learned and where do we go from here?
P2860
Q24320601-766EE88C-3316-445A-A689-087A63C7701DQ24643909-9AF6D8B7-2057-4B28-9044-3BD7099B2541Q26782490-E4AB6871-7677-4E06-882B-B40A3C79D842Q26852281-A243AE85-3475-4FE6-B6E7-8296718021A2Q27021682-E0503351-2F50-4C42-A730-291FD20875C1Q27307826-83FC9677-F286-4354-9E5C-56D239A0E17AQ30477079-66F4D7D9-ADCC-414A-A2EA-89BDF9A0A5CAQ33202467-055E2104-F11D-4F99-A009-FE897EB2F89FQ33533576-7FD96532-3AF3-4560-B823-F3ED3B11A859Q33633043-421B5DA9-F4A9-405D-A2A1-41CA036A5771Q33829000-B29A5C7E-F405-45C3-936C-FBA81D933786Q34161023-0485601B-A188-432B-BFAA-C0E1C96994EBQ34170510-484DB4AA-9395-45F5-8A57-1A62FE878675Q34278355-B494227F-3E0B-4287-8EDA-E10AB647D197Q34354241-1C9F2F34-7611-4709-816E-04CDBBC14101Q34376269-834F06AE-D973-4D70-9C0C-8678F95504F4Q34552344-3035BFBE-F3B0-418A-B4BA-C3CB99583D07Q34586747-FEC37AC6-FF22-4CB8-A962-A224AD5D401FQ34652071-AE53A7FE-7E1F-406C-851A-109CD6FCBC98Q34775987-98E35D9C-F0C7-4C4C-B433-F2D4186D593AQ34807482-C24F1889-0A64-4B0A-844E-8B4B9EB49A34Q34979750-8EACD3E2-BDC3-473C-A3F6-C3E893A666AFQ35050535-6CAB29E1-B883-4AA2-9927-F5456EB7D9C7Q35084882-F1C45E6C-29BE-4AEE-8A86-DE7FE6CEF8AEQ35103074-2A05FAB5-2088-4AD4-8755-8D51627D77D8Q35137488-A4E556B6-A3F6-4B62-8812-2222B93A92AEQ35161238-EAFDAA63-0714-4A85-81AF-6E45ED98F458Q35472231-13587B9E-6E57-44D1-A8B7-2A81C362265AQ35722521-CC7E54BF-096E-440E-B3A2-7399439E2C03Q35841731-3C96EDA8-EFE0-47B6-91BD-ACEC7F713E23Q35947448-C5D0219A-4721-4D85-99EA-33743365F145Q36739538-9B6F07CB-4F48-4941-9DA5-C1098C036DFEQ36951847-138EF7B9-6849-4092-922A-0806E7B482E8Q37002807-4BE9B34D-E3E1-46BF-ACB3-94AC9D9D1365Q37053847-42343522-EEE9-42F3-9C1E-09949FA36834Q37057920-BB71E9AC-A200-41ED-A2A5-AE26D2344471Q37075802-B065F95B-F427-4994-9C2B-375206B1514EQ37090083-93CD60D1-9296-42F4-9F1E-BA634182D62AQ37127867-D680C369-AF72-4F5A-9800-D4A28FF56FB1Q37147787-E11CF788-5258-459B-BCA4-6CC416802D53
P2860
Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Selective vulnerability of cor ...... aging and Alzheimer's disease.
@ast
Selective vulnerability of cor ...... aging and Alzheimer's disease.
@en
Selective vulnerability of cor ...... aging and Alzheimer's disease.
@nl
type
label
Selective vulnerability of cor ...... aging and Alzheimer's disease.
@ast
Selective vulnerability of cor ...... aging and Alzheimer's disease.
@en
Selective vulnerability of cor ...... aging and Alzheimer's disease.
@nl
prefLabel
Selective vulnerability of cor ...... aging and Alzheimer's disease.
@ast
Selective vulnerability of cor ...... aging and Alzheimer's disease.
@en
Selective vulnerability of cor ...... aging and Alzheimer's disease.
@nl
P1476
Selective vulnerability of cor ...... aging and Alzheimer's disease.
@en
P2093
John H Morrison
Patrick R Hof
P304
P356
10.1016/S0079-6123(02)36039-4
P577
2002-01-01T00:00:00Z